TGA Approval

RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial (427684)

ARTG ID

427684

ARTG Name

RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial

Sponsor

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

ARTG Date

February 7, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

UCB Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/1b03835b781487686085b9f060ed4e52.pdf

https://medical-cdn.nocode.com/drug_tga/ca424e37f8da16756945afefdf6ec3c4.pdf

Ingredient Name

rozanolixizumab

Empowering clinical research with data-driven insights and AI-powered tools.

RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial (427684) - TGA 批准文号 | MedPath